Success Stories: Indian Scientist in Virology Gets EB1-A Approval in Just 11 Days, with Our Excellent Case Preparation Tactics and Premium Processing Upgrade
Client’s Testimonial:
“Thanks a lot for your help and support all through the steps!”
On November 23rd, 2021, we received another EB-1A (Alien of Extraordinary Ability) approval for a Scientist in the Field of Virology (Approval Notice).
General Field: Virology
Position at the Time of Case Filing: Scientist
Country of Origin: India
State of Residence at the Time of Filing: North Carolina
Approval Notice Date: November 23rd, 2021
Processing Time: 11 days (Premium Processing Requested)
Case Summary:
“[The client] possesses an exemplary track record of original and impactful research that meaningfully advances the scientific effort to develop effective treatments for dangerous viral infections. She has clearly established herself among the leading virologists working in the United States today and therefore represents an irreplaceable national asset.”
“[The client] has taken additional steps with her research to identify molecular targets for the development of new therapeutics against influenza and other viral diseases. As a researcher, she stands apart from her peers, conducting investigations that directly address critical challenges in virology and overall public health.”
These are excerpts taken from letters of recommendation our Indian client obtained for her EB1-A (Alien of Extraordinary Ability) approval. As is evident from the name, the category calls for hard evidence of the petitioner’s extraordinary ability in the proposed area of research. With our client, her expertise lay in the field of virology. With a Ph.D. in Viral Immunology, she was employed as a scientist while applying for her EB1-A visa. Since the regulations set by the USCIS for this category are very stringent, our team of experts went the extra mile to prove that her case indeed had merit. For this we took care of the following apart from the letters of recommendation:
- We showed that she was well-known for more than a decade of research towards the discovery of new antiviral drugs and vaccines for common viral infections, such as influenza and measles. Furthermore, her work has recently become of critical value as the coronavirus pandemic continues to threaten public and economic health all over the world.
- We showed that she has actively engaged her peers in the field of virology by authoring and co-authoring 11 peer-reviewed scientific articles and 1 patent that have been published in international journals.
- We also showed that she has 298 citations for these publications proving her wide reach in the area.
- Finally, we showed that she had also conducted 25 reviews for international scientific journals in the field thus proving her to be a reliable asset to the field of research.